Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial
暂无分享，去创建一个
P. Hari | Bryon D Johnson | R. Orentas | A. Szabo | A. Worden | M. Kadan | D. Schneider | B. Dropulić | A. Cunningham | N. Shah | M. Hamadani | T. Fenske | W. Krueger | C. Keever-Taylor | F. Zhu | Sharon Yim | Bryon D. Johnson | Ashley M Cunningham